Ftse Mib
33.629,21
0,00%
DAX
17.993,69
0,00%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.246,00
0,39%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cardiff Oncology Inc (CRDF) Cardiff Oncology Inc (CRDF) Notizie

Cardiff Oncology Inc

CRDF
3,50
-0,98 (-21,87%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202422:05GLOBECardiff Oncology Reports First Quarter 2024 Results and..
25/4/202422:05GLOBECardiff Oncology to Report First Quarter 2024 Results and..
08/4/202422:05GLOBECardiff Oncology Presents Novel Preclinical Data at AACR..
08/3/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05GLOBECardiff Oncology Announces Upcoming Presentations at the..
29/2/202422:07GLOBECardiff Oncology Reports Fourth Quarter and Full Year 2023..
29/2/202422:06GLOBECardiff Oncology Provides Clinical Update on Phase 2..
29/2/202422:05GLOBECardiff Oncology Announces First Patient Dosed in Randomized..
29/2/202422:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202414:00GLOBECardiff Oncology to Present at the Cowen 44th Annual Health..
22/2/202414:00GLOBECardiff Oncology to Report Fourth Quarter and Full Year 2023..
06/2/202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202416:30PRNUSCardiff Oncology Announces Publication of Data from Phase 1b..
08/1/202415:12EDGAR2Form 8-K - Current report
20/11/202322:05PRNUSCardiff Oncology to Present at the 35th Annual Piper Sandler..
02/11/202321:06EDGAR2Form 8-K - Current report
02/11/202321:05PRNUSCardiff Oncology Reports Third Quarter 2023 Results and..
02/11/202321:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202322:05PRNUSCardiff Oncology to Report Third Quarter 2023 Financial..
26/9/202322:07EDGAR2Form 8-K - Current report
26/9/202322:05PRNUSCardiff Oncology Announces Positive Clinical Data in..
05/9/202314:00PRNUSCardiff Oncology to Present at Upcoming Investor Conferences..
09/8/202322:06EDGAR2Form 8-K - Current report
09/8/202322:05PRNUSCardiff Oncology Reports Second Quarter 2023 Results and..
09/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:42EDGAR2Form 8-K - Current report
07/8/202322:05PRNUSCardiff Oncology Announces New Lead Program in First-Line..
24/7/202323:13EDGAR2Form 8-K - Current report
24/7/202323:09PRNUSCardiff Oncology Reports Inducement Grant Under Nasdaq..
20/6/202323:22PRNUSCardiff Oncology Reports Inducement Grant Under Nasdaq..
05/6/202314:00PRNUSCardiff Oncology to Present at the Jefferies Healthcare..
Apertura: 3,96 Min: 3,12 Max: 4,42
Chiusura: 4,48

La tua Cronologia

NASDAQ
CRDF
Cardiff Oncology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network